Geode Capital Management’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47M | Buy |
|
|||||
|
2025
Q1 | $1.77M | Buy |
|
|||||
|
2024
Q4 | $849K | Buy |
|
|||||
|
2024
Q3 | $94.8K | Buy |
|
|||||
|
2024
Q2 | $44.9K | Buy |
|
|||||
|
2024
Q1 | $28.1K | Hold |
|
|||||
|
2023
Q4 | $14K | Hold |
|
|||||
|
2023
Q3 | $23.5K | Sell |
|
|||||
|
2023
Q2 | $35.8K | Hold |
|
|||||
|
2023
Q1 | $59.5K | Hold |
|
|||||
|
2022
Q4 | $99K | Buy |
|
|||||
|
2022
Q3 | $59K | Hold |
|
|||||
|
2022
Q2 | $85K | Hold |
|
|||||
|
2022
Q1 | $100K | Hold |
|
|||||
|
2021
Q4 | $126K | Hold |
|
|||||
|
2021
Q3 | $189K | Buy |
|
|||||
|
2021
Q2 | $169K | Buy |
|
|||||
|
2021
Q1 | $163K | Buy |
|